Alkermes
ALKS
#2326
Rank
NZ$14.23 B
Marketcap
NZ$84.70
Share price
3.08%
Change (1 day)
63.83%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): NZ$0.30 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.65 Billion. In 2025 the company made an earning of NZ$0.54 Billion a decrease over its 2024 earnings that were of NZ$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.30 B-44.82%
2025 NZ$0.54 B-34.87%
2024 NZ$0.84 B-17.97%
2023 NZ$1.02 B-468.52%
2022 -NZ$0.28 Billion449.24%
2021 -NZ$50.79 Million-68.04%
2020 -NZ$0.16 Billion-52.1%
2019 -NZ$0.34 Billion64.49%
2018 -NZ$0.21 Billion-15.04%
2017 -NZ$0.24 Billion-34.2%
2016 -NZ$0.37 Billion-5.34%
2015 -NZ$0.39 Billion35084.97%
2014 -NZ$1.09 Million
2012 NZ$13.42 M-117.81%
2011 -NZ$75.36 Million-12.69%
2010 -NZ$86.32 Million94.3%
2009 -NZ$44.43 Million-117.7%
2008 NZ$0.25 B622.63%
2007 NZ$34.73 M
2004 -NZ$0.14 Billion-14.48%
2003 -NZ$0.17 Billion11.88%
2002 -NZ$0.15 Billion39.65%
2001 -NZ$0.11 Billion5.73%
2000 -NZ$97.23 Million-28.91%
1999 -NZ$0.14 Billion237.28%
1998 -NZ$40.55 Million100.05%
1997 -NZ$20.27 Million-37.93%
1996 -NZ$32.66 Million82.72%
1995 -NZ$17.88 Million-26.79%
1994 -NZ$24.41 Million-72.78%
1993 -NZ$89.68 Million208.07%
1992 -NZ$29.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.84 B 10,618.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$22.85 B 7,138.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.59 B 3,889.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.08 B 4,359.14%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$20.48 B 6,388.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.28 B 8,539.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-NZ$0.39 Billion-221.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.5 Billion-255.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.21 B 600.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel